|
Mastijet Forte
|
-
|
V/NRP/96/0344
|
Intervet International B.V., Nīderlande
|
QJ51RV01
|
lactating cows
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/96/0344-01 |
|
20 |
Injektors, 1 deva |
[PDF]
[PDF]
|
|
|
T61
|
-
|
V/NRP/02/1429
|
Intervet International B.V., Nīderlande
|
QN51AX50
|
guinea pigs; hamsters; cattle; pigs; horses; mouses; rats; dogs; cats; rabbits; minks; pigeons
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/02/1429-01 |
|
1 |
Stikla pudele (dzintarkrāsas), 50 ml |
-
|
|
|
Hefrotrim
|
-
|
V/NRP/95/0251
|
Alivira Animal Health Limited,, Īrija
|
QJ01EW03
|
cattle; pigs; horses; dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/95/0251-01 |
|
1 |
Stikla pudelīte, 50 ml |
-
|
| V/NRP/95/0251-02 |
|
1 |
Stikla flakons, 100 ml |
-
|
| V/NRP/95/0251-03 |
|
10 |
Stikla pudelīte, 50 ml |
-
|
| V/NRP/95/0251-04 |
|
12 |
Stikla flakons, 100 ml |
-
|
|
|
Ingelvac MycoFLEX
|
-
|
V/MRP/09/0014
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI09AB13
|
pigs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/09/0014-08 |
|
12 |
ABPE pudele, 250 ml |
-
|
| V/MRP/09/0014-09 |
|
1 |
ABPE pudele, 50 ml |
-
|
| V/MRP/09/0014-10 |
|
1 |
ABPE pudele, 10 ml |
-
|
| V/MRP/09/0014-11 |
|
12 |
ABPE pudele, 10 ml |
-
|
| V/MRP/09/0014-12 |
|
12 |
ABPE pudele, 50 ml |
-
|
| V/MRP/09/0014-13 |
|
1 |
ABPE pudele, 250 ml |
-
|
| V/MRP/09/0014-14 |
|
1 |
ABPE pudele, 100 ml |
-
|
| V/MRP/09/0014-15 |
|
12 |
ABPE pudele, 100 ml |
-
|
| V/MRP/09/0014-16 |
|
12 |
ABPE TwistPak pudele, 250 ml |
-
|
| V/MRP/09/0014-17 |
|
1 |
ABPE TwistPak pudele, 50 ml |
-
|
| V/MRP/09/0014-18 |
|
1 |
ABPE TwistPak pudele, 10 ml |
-
|
| V/MRP/09/0014-19 |
|
12 |
ABPE TwistPak pudele, 10 ml |
-
|
| V/MRP/09/0014-20 |
|
12 |
ABPE TwistPak pudele, 50 ml |
-
|
| V/MRP/09/0014-21 |
|
1 |
ABPE TwistPak pudele, 250 ml |
-
|
| V/MRP/09/0014-22 |
|
1 |
ABPE TwistPak pudele, 100 ml |
-
|
| V/MRP/09/0014-23 |
|
12 |
ABPE TwistPak pudele, 100 ml |
-
|
|
|
Avishield ND B1
|
-
|
V/DCP/18/0017
|
Izo S.r.l., Itālija
|
QI01AD06
|
chickens
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/18/0017-01 |
|
10 |
Stikla flakons, 1000 deva |
-
|
| V/DCP/18/0017-02 |
|
10 |
Stikla flakons, 2500 deva |
-
|
| V/DCP/18/0017-03 |
|
10 |
Stikla flakons, 5000 deva |
-
|
|
|
Avishield IB QX
|
-
|
V/DCP/25/0049
|
Izo S.r.l., Itālija
|
QI01AD07
|
chickens
|
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/25/0049-01 |
|
10 |
Stikla flakons, 1000 deva |
-
|
| V/DCP/25/0049-02 |
|
10 |
Stikla flakons, 2500 deva |
-
|
| V/DCP/25/0049-03 |
|
10 |
Stikla flakons, 5000 deva |
-
|
|
|
Bimacure
|
500 mg
|
V/DCP/22/0029
|
Bimeda Animal Health Limited, Īrija
|
QG51AA05
|
cattle
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/22/0029-01 |
|
10 |
polietilēna šļirce, 19 g |
-
|
|
|
BIOSUIS Entero
|
-
|
V/DCP/24/0028
|
Bioveta a.s., Čehija
|
QI09AL09
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Porcine rotavirus, serogroup A, strain OSU 6, Inactivated, Escherichia coli, serotype O149:K88 (fimbrial adhesin F4ac), Inactivated, Escherichia coli, serotype O101:K99 (fimbrial adhesins F5 and F41), Inactivated, Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated, Clostridium perfringens, type C, beta toxoid
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Bioveta a.s., Čehija
|
| Date of authorisation/renewal: |
10-Apr-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (11-Apr-2024)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (11-Apr-2024)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (11-Apr-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/24/0028-01 |
|
1 |
Stikla flakons, 10 ml |
-
|
| V/DCP/24/0028-02 |
|
1 |
Stikla flakons, 50 ml |
-
|
| V/DCP/24/0028-03 |
|
1 |
Stikla flakons, 100 ml |
-
|
| V/DCP/24/0028-04 |
|
1 |
ABPE flakons, 50 ml |
-
|
| V/DCP/24/0028-05 |
|
1 |
ABPE flakons, 100 ml |
-
|
| V/DCP/24/0028-06 |
|
1 |
ABPE flakons, 250 ml |
-
|
| V/DCP/24/0028-07 |
|
10 |
Stikla flakons, 10 ml |
-
|
|
|
Karbetocin Bioveta
|
0.07 mg/ml
|
V/DCP/25/0072
|
Bioveta a.s., Čehija
|
QH01BB03
|
cattle; pigs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/25/0072-01 |
|
1 |
Stikla flakons, 10 ml |
-
|
| V/DCP/25/0072-02 |
|
1 |
Stikla flakons, 50 ml |
-
|
|
|
Kelevo
|
800 µg/tabl.
|
V/DCP/21/0032
|
Industrial Veterinaria, S.A., Spānija
|
QH03AA01
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/21/0032-01 |
|
5 |
Alumīnija blisteris, 10 tablete |
-
|
| V/DCP/21/0032-02 |
|
10 |
Alumīnija blisteris, 10 tablete |
-
|
| V/DCP/21/0032-03 |
|
10 |
Alumīnija blisteris, 25 tablete |
-
|
| V/DCP/21/0032-04 |
|
25 |
Alumīnija blisteris, 10 tablete |
-
|
| V/DCP/21/0032-05 |
|
2 |
Alumīnija blisteris, 25 tablete |
-
|
| V/DCP/21/0032-06 |
|
4 |
Alumīnija blisteris, 25 tablete |
-
|
|
|
Kelevo
|
400 µg/tabl.
|
V/DCP/21/0033
|
Industrial Veterinaria, S.A., Spānija
|
QH03AA01
|
dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/21/0033-01 |
|
5 |
Alumīnija blisteris, 10 tablete |
-
|
| V/DCP/21/0033-02 |
|
10 |
Alumīnija blisteris, 25 tablete |
-
|
| V/DCP/21/0033-03 |
|
10 |
Alumīnija blisteris, 10 tablete |
-
|
| V/DCP/21/0033-04 |
|
25 |
Alumīnija blisteris, 10 tablete |
-
|
| V/DCP/21/0033-05 |
|
2 |
Alumīnija blisteris, 25 tablete |
-
|
| V/DCP/21/0033-06 |
|
4 |
Alumīnija blisteris, 25 tablete |
-
|
|
|
Kelevo
|
200 µg/tabl.
|
V/DCP/21/0034
|
Industrial Veterinaria, S.A., Spānija
|
QH03AA01
|
dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/21/0034-01 |
|
5 |
Alumīnija blisteris, 10 tablete |
-
|
| V/DCP/21/0034-02 |
|
10 |
Alumīnija blisteris, 25 tablete |
-
|
| V/DCP/21/0034-03 |
|
10 |
Alumīnija blisteris, 10 tablete |
-
|
| V/DCP/21/0034-04 |
|
25 |
Alumīnija blisteris, 10 tablete |
-
|
| V/DCP/21/0034-05 |
|
2 |
Alumīnija blisteris, 25 tablete |
-
|
| V/DCP/21/0034-06 |
|
4 |
Alumīnija blisteris, 25 tablete |
-
|
|
|
Ketosol-100
|
100 mg/ml
|
V/MRP/18/0035
|
Interchemie Werken De Adelaar Eesti AS, Igaunija
|
QM01AE03
|
cattle; pigs; horses
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/18/0035-01 |
|
1 |
Stikla flakons, 100 ml |
-
|
| V/MRP/18/0035-02 |
|
1 |
Stikla flakons, 50 ml |
-
|
|
|
Ketabel
|
100 mg/ml
|
V/DCP/20/0038
|
Bela-pharm GmbH&Co.KG, Vācija
|
QN01AX03
|
guinea pigs; hamsters; cattle; pigs; sheep; goats; horses; mouses; rats; dogs; cats; rabbits
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/20/0038-01 |
|
1 |
Stikla flakons, 10 ml |
-
|
| V/DCP/20/0038-02 |
|
10 |
Stikla flakons, 10 ml |
-
|
| V/DCP/20/0038-03 |
|
1 |
Stikla flakons, 25 ml |
-
|
| V/DCP/20/0038-04 |
|
10 |
Stikla flakons, 25 ml |
-
|
|
|
Biomectin 1%
|
10 mg/ml
|
V/NRP/96/0466
|
Vetoquinol Biowet Sp. z o.o., Polija
|
QP54AA01
|
cattle; pigs; sheep
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/96/0466-01 |
10 mg/ml |
1 |
Stikla flakons, 20 ml |
-
|
| V/NRP/96/0466-02 |
10 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
| V/NRP/96/0466-03 |
10 mg/ml |
1 |
Stikla flakons, 100 ml |
-
|
| V/NRP/96/0466-04 |
10 mg/ml |
1 |
Stikla flakons, 250 ml |
-
|
| V/NRP/96/0466-05 |
10 mg/ml |
1 |
Plastmasas flakons, 500 ml |
-
|
|
|
Zoletil 100
|
-
|
V/NRP/07/1711
|
Virbac S.A., Francija
|
QN01AX99
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for solution for injection
|
| International name (active substance): |
Zolazepam hydrochloride, Tiletamine hydrochloride
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
Virbac S.A., Francija
|
| Date of authorisation/renewal: |
15-Jan-2013
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOCX] 11112025LI (11-Nov-2025)
|
| Labelling text: |
[DOCX] 11112025M (11-Nov-2025)
|
| Summary of product characteristics: |
[DOCX] 11112025ZA (11-Nov-2025)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/07/1711-01 |
|
1 |
Flakons (šķīdinātājs), 5 ml;Flakons (liofilizāts), 970 mg |
-
|
|
|
Fypryst 402 mg
|
-
|
V/DCP/10/0010
|
KRKA, d.d., Novo mesto, Slovēnija
|
QP53AX15
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/10/0010-01 |
402 mg |
3 |
Plastikāta tūbiņa, 1 deva |
-
|
| V/DCP/10/0010-02 |
402 mg |
1 |
Plastikāta tūbiņa, 1 deva |
-
|
| V/DCP/10/0010-03 |
402 mg |
6 |
Plastikāta tūbiņa, 1 deva |
-
|
| V/DCP/10/0010-04 |
402 mg |
10 |
Plastikāta tūbiņa, 1 deva |
-
|
| V/DCP/10/0010-05 |
402 mg |
20 |
Plastikāta tūbiņa, 1 deva |
-
|
|
|
Trymox LA
|
150 mg/ml
|
V/DCP/19/0019
|
Univet Ltd., Īrija
|
QJ01CA04
|
cattle; pigs; sheep; dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/19/0019-01 |
150 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
| V/DCP/19/0019-02 |
150 mg/ml |
1 |
Stikla flakons, 100 ml |
-
|
| V/DCP/19/0019-03 |
150 mg/ml |
1 |
Stikla flakons, 250 ml |
-
|
| V/DCP/19/0019-04 |
150 mg/ml |
1 |
PET pudele, 100 ml |
-
|
| V/DCP/19/0019-05 |
150 mg/ml |
1 |
PET pudele, 250 ml |
-
|
| V/DCP/19/0019-06 |
150 mg/ml |
12 |
Stikla flakons, 50 ml |
-
|
| V/DCP/19/0019-07 |
150 mg/ml |
12 |
Stikla flakons, 100 ml |
-
|
| V/DCP/19/0019-08 |
150 mg/ml |
12 |
PET pudele, 100 ml |
-
|
| V/DCP/19/0019-09 |
150 mg/ml |
6 |
Stikla flakons, 250 ml |
-
|
| V/DCP/19/0019-10 |
150 mg/ml |
6 |
PET pudele, 250 ml |
-
|
|
|
Telmitraxx
|
4 mg/ml
|
V/DCP/23/0024
|
Alfasan Nederland BV, Nīderlande
|
QC09CA07
|
cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/23/0024-01 |
|
1 |
ABPE pudele, 30 ml |
-
|
| V/DCP/23/0024-02 |
|
1 |
ABPE pudele, 60 ml |
-
|
| V/DCP/23/0024-03 |
|
1 |
ABPE pudele, 90 ml |
-
|
| V/DCP/23/0024-04 |
|
1 |
ABPE pudele, 200 ml |
-
|
|
|
Vetmedin S
|
2.5 mg
|
V/MRP/15/0012
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QC01CE90
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/15/0012-01 |
2,5 mg |
2 |
PVH/Al blisteris, 10 tablete |
-
|
| V/MRP/15/0012-02 |
2,5 mg |
5 |
PVH/Al blisteris, 10 tablete |
-
|
| V/MRP/15/0012-03 |
2,5 mg |
10 |
PVH/Al blisteris, 10 tablete |
-
|
|